Hollywood actress and U.N. humanitarian Angelina Jolie made a surprise visit to one of the worst flood-hit areas in southern Pakistan on Tuesday, officials said, as the death toll from months-long deluges rose to 1,559.

TV footage showed Jolie arriving at an airport in Karachi, the capital of southern Sindh province, where floods since mid-June have killed 692 people, damaged hundreds of thousands of homes and left half a million people homeless.

Later, she visited some of the flood-affected areas, according to local media.

According to the IRC, a prominent international aid group, Jolie is visiting Pakistan to support communities affected by the devastating floods.

There was no comment from the government about Jolie’s visit to Dadu, one of the worst-hit districts where waterborne diseases have also caused nearly 300 deaths since July. Currently, doctors are trying to contain the outbreak of waterborne diseases among flood survivors.

The visit comes as Pakistan’s Prime Minister Shahbaz Sharif is in New York for the 77th session of the U.N. General Assembly. In his speech, Sharif will highlight the damages caused by climate-change induced floods in the impoverished country.

Pakistan says the floods have caused $30 billion in damages to the country’s economy.
…

Officials in Uganda have confirmed an outbreak of the deadly Ebola virus. The country’s Ministry of Health says a young man died of the virus in central Uganda Monday, and several of his relatives who died earlier this month are also suspected to have had Ebola. The government has sent a rapid response team to the area to investigate. 

Uganda’s Ministry of Health officials say the suspected Ebola case was identified Saturday in a village in the central Mubende district.  

The ministry’s permanent secretary, Dr. Diana Atwine, says a 24-year-old man was admitted to a hospital for pneumonia and diarrhea.  

But his symptoms also included those of the deadly virus — a dry cough, high fever, convulsions, blood-stained vomit and bleeding in the eyes. 

Speaking at a press conference Tuesday, Atwine said the clinical team and the Uganda Virus Research Institute conducted tests for Ebola.

“The results were released yesterday evening and they confirmed Ebola, the Sudan strain,” she said. “Unfortunately, that morning of 19th, the patient who had been confirmed with Ebola passed on.”

Atwine said six of the man’s relatives who died earlier this month — three adults and three children from the same family — also may have had Ebola. 

The World Health Organization’s Uganda office says there are eight more people with suspected cases that are receiving care at a health facility.  

Uganda’s health ministry has yet to identify the source of the infection but suspects wildlife to human contact.

A rapid response team was sent to Mubende to investigate, put in place control measures, and use rapid testing on contacts in the community. 

But the World Health Organization says vaccinating those who were in contact with the infected or someone linked to them, known as ring vaccination, will not be possible.

WHO-Uganda’s head of disease prevention and control, Dr. Bayo Fatunmbi, told the briefing there is currently no effective vaccine available for the Sudan strain of Ebola.

“The ring vaccination that worked with [the] Zaire virus, will not be useful for this particular Sudan strain,” he said. “But there’s another type of vaccine, Johnson and Johnson, that is being tested currently [to see] whether it will be useful for this particular strain.”

The WHO says ring vaccination has been highly effective in controlling the spread of the Zaire strain in recent Ebola outbreaks in the Democratic Republic of Congo.

The WHO says Uganda’s last Ebola outbreak in 2019 was the Zaire strain. Uganda last reported the relatively rare Sudan strain outbreak in 2012.  

The U.S. Centers for Disease Control and Prevention is helping Uganda deal with this latest outbreak.  

Amy Boore, the CDC’s Global Health Protection program director, told reporters they were prepared to assist the Uganda Virus Research Institute.

“CDC headquarters is already in communication with UVRI (Uganda Virus Research Institute) and is already helping them develop plans for how they will continue to test and expand testing and have all the support they need during this,” she said.

Ebola is spread through bodily fluids and causes a hemorrhagic fever that kills up to 90% of those infected.  The WHO says case fatality rates of the Sudan virus have varied from 41% to 100% in past outbreaks.

The Sudan strain of Ebola, discovered in Sudan in 1976, is less common than the Zaire strain that was found that same year.

The Zaire strain of Ebola was named after the country and river where it was found, the Ebola River in the former Democratic Republic of Congo (DRC).  

The DRC’s name was changed to Zaire in 1971 then changed back to Democratic Republic of Congo in 1997.  

Health authorities in the neighboring DRC in late August declared a resurgence of Ebola after confirming a case in the country’s eastern North Kivu province.  

It was the fifteenth resurgent outbreak recorded in the DRC.
…

A bay-breasted warbler weighs about the same as four pennies, but twice a year makes an extraordinary journey. The tiny songbird flies nearly 4,000 miles (6,437 kilometers) between Canada’s spruce forests and its wintering grounds in northern South America.

“Migratory birds are these little globetrotters,” said Jill Deppe, the senior director of the migratory bird initiative at the National Audubon Society.

A new online atlas of bird migration, published on Thursday, draws from an unprecedented number of scientific and community data sources to illustrate the routes of about 450 bird species in the Americas, including the warblers.

The Bird Migration Explorer mapping tool, available free to the public, is an ongoing collaboration between 11 groups that collect and analyze data on bird movements, including the Cornell Lab of Ornithology, Smithsonian Migratory Bird Center, the U.S. Geological Survey, Georgetown University, Colorado State University, and the National Audubon Society.

For the first time, the site will bring together online data from hundreds of scientific studies that use GPS tags to track bird movements, as well as more than 100 years of bird-banding data collected by USGS, community science observations entered into Cornell’s eBird platform, genomic analysis of feathers to pinpoint bird origins, and other data.

“The past twenty years have seen a true renaissance in different technologies to track bird migrations around the world at scales that haven’t been possible before,” said Peter Marra, a bird migration expert at Georgetown University who collaborated on the project.

The site allows a user to enter a species — for instance, osprey — and watch movements over the course of a year. For example, data from 378 tracked ospreys show up as yellow dots that move between coastal North America and South America as a calendar bar scrolls through the months of the year.

Or users can enter the city where they live and click elsewhere on the map for a partial list of birds that migrate between the two locations. For example, ospreys, bobolinks and at least 12 other species migrate between Washington, D.C. and Fonte Boa, Brazil.

As new tracking data becomes available, the site will continue to expand. Melanie Smith, program director for the site, said the next phase of expansion will add more data about seabirds.

Washington, D.C. resident Michael Herrera started birdwatching about four months ago and was quickly hooked. “It’s almost like this hidden world that’s right in front of your eyes,” he said. “Once you start paying attention, all these details that were like background noise suddenly have meaning.”

Herrera said he’s eager to learn more about the migratory routes of waterbirds in the mid-Atlantic region, such as great blue herons and great egrets.

Georgetown’s Marra hopes that engaging the public will help spotlight some of the conservation challenges facing birds, including loss of habitat and climate change.

In the past 50 years, the population of birds in the U.S. and Canada has dropped nearly 30%, with migratory species facing some of the steepest declines.
…

Marking World Patient Safety Day, Saturday, the World Health Organization warns unsafe medication practices and errors are a leading cause of avoidable harm in world health care systems. 

The WHO is calling for urgent action to stop the medication errors putting millions at risk of severe harm or even death.  

The agency’s quality of care coordinator, Neelam Dhingra-Kumar, noted everyone will, at some point take medicine, expecting to benefit.  However, she said they can be harmful with improper use.

“There is ample evidence around the world that unsafe medication practices and medication errors is actually avoidable,” she said. “Such as incorrect prescriptions, wrong dispensing, wrong use of medicines, lack of proper monitoring. Once the physicians prescribe medicines, they are not monitored and even use of substandard and falsified medicines are a leading cause of avoidable harm in health care systems.”

The WHO said half of all preventable harm in medical care is medication-related and that a quarter of these patients suffer clinically severe or life-threatening harm.

It said the elderly are most at risk, especially those taking multiple medications. It said high rates of medication-related harm also occur in surgical care, intensive care, and emergency medicine.

Dhingra-Kumar said the amount of harm related to medication is twice as prevalent in low- and middle-income countries as in rich countries.

“That is primarily because of weak medication systems, lack of resources, lack of human workforce, not a fully trained workforce,” she said. “And even the culture; it is very, very difficult to change cultures as seen as very deeply in the system of blame.”  

She said medication errors often are caused by such human factors as fatigue, poor environmental conditions, and staff shortages. 

The WHO says medication practices and medication errors are a main cause of injury and avoidable harm in health care systems.  It estimates the global cost associated with medication errors at $42 billion a year. 
…

Two Chinese astronauts went on a spacewalk Saturday from a new space station that is due to be completed later this year.

Cai Xuzhe and Chen Dong’s installed pumps, a handle to open the hatch door from outside in an emergency, and a foot-stop to affix an astronaut’s feet to a robotic arm, state media said.

China is building its own space station after being excluded by the U.S. from the International Space Station because its military runs the country’s space program. American officials see a host of strategic challenges from China’s space ambitions, in an echo of the U.S.-Soviet rivalry that prompted the race to the moon in the 1960s.

The latest spacewalk was the second during a six-month mission that will oversee the completion of the space station. The first of two laboratories, a 23-ton module, was added to the station in July and the other is to be sent up later this year.

The third member of the crew, Liu Yang, supported the other two from inside during the spacewalk. Liu and Chen conducted the first spacewalk about two weeks ago.

They will be joined by three more astronauts near the end of their mission in what will be the first time the station has six people on board.

China became the third nation to send a person into space in 2003, following the former Soviet Union and the United States. It has sent rovers to the moon and Mars and brought lunar samples back to Earth.
…

Research to develop a pill form of insulin is showing promise at the University of British Columbia in western Canada. The goal is to eliminate the need for diabetics to inject themselves with the lifesaving medication.

According to the World Health Organization, there are an estimated 422 million diabetics worldwide. The disease claims 1.5 million lives each year. The U.S. Centers for Disease Control and Prevention estimates 30 million Americans have diabetes.

Although widely available in the developed world, current forms of insulin require refrigeration, which can be a stumbling block in developing nations.

An oral version of insulin, in the form of an everyday pill, could change everything, making it easier and cheaper to transport and distribute — even to remote regions of the planet.

Researchers at the University of British Columbia in Vancouver think they might have discovered a formula for a pill that effectively delivers a full dose of insulin to a patient’s liver — where it is needed to regulate blood sugar levels — without dissipating uselessly in the stomach.

The trick is to not swallow the pill, according to Anubhav Pratap-Singh, an assistant professor at the school’s Faculty of Land and Food Systems and the project’s lead researcher. He said the pill can be absorbed in the mouth by wedging it between the cheek and gums. In laboratory studies on rats, full doses of insulin reached the liver, he said.

“So we are getting quite a high amount of yield and so we hope that this will be more economical,” Pratap-Singh said.

Pratap-Singh started studying oral insulin in 2018, inspired to help his diabetic father, who has to inject insulin multiple times a day. He said a pill form would increase the quality of life for millions of patients who use insulin around the world.

“Instead of having to take insulin and having to travel with it in refrigerated boxes, one will simply have [a] normal capsule or tablet in a normal wrapper, which will be shelf stable, and very, very affordable,” Pratap-Singh said.

Dr. Daniel Drucker is professor of medicine at the Lunenfeld-Tanenbaum Research Institute and the University of Toronto. He said previous attempts at oral insulin failed to efficiently deliver enough of the drug within the body. To compensate, huge pill doses were required that would have driven prices higher for the drug.

“We have to pay the manufacturing costs of a large amount of insulin in this case that never makes it into the body,” Drucker said.

Drucker said new insulin pumps, which act as an artificial pancreas, have become increasingly effective in treating diabetes. He also said the development of cell-based insulin replacement therapy, which would create beta cells that automatically release necessary insulin, look promising.

For Pratap-Singh and other researchers, the next steps involve years of further testing of what could be a revolutionary method of insulin delivery.
…

The World Health Organization has declared an end to Ghana’s outbreak of the deadly Marburg virus after more than six weeks without any new cases. 

Three cases of the virus were recorded in the West African country in late June, killing two people. 

Marburg is a highly infectious viral hemorrhagic fever in the same family as Ebola. The symptoms of Marburg include diarrhea, fever, nausea and vomiting. 

Speaking at a press conference Friday in Accra, head of the Ghana Health Service, Dr. Patrick Kuma-Aboagye, said having passed the mandatory 42-day period without a new case, the country is now free of the virus. 

“I do hereby state that, the appropriate outbreak reasons to Marburg disease have been implemented during the 42 days, following the last negative PCR test result for the sole surviving patient with recommendation from WHO,” he said. “Ghana has, therefore, successfully interrupted the first Marburg virus disease outbreak and hereby declare that the outbreak is over.”

A total of 198 people were tested for the virus when it first broke in Ghana. They all tested negative. 

It is the second time Marburg made a West African appearance. The first outbreak was in Guinea in September of last year. 

Marburg has also appeared in Angola, the Democratic Republic of the Congo, Kenya, South Africa and Uganda. 

There are no vaccines or antiviral treatments for Marburg, but WHO says supportive care — rehydration with oral or intravenous fluids — and treatment of specific symptoms improves the rate of survival. 

 
…

Mount Everest base camp, a sprawling tent village that is home away from home during climbing season for hundreds of aspiring summiteers and support staff, may soon be on the move.

Nepalese officials say they are considering the move to a lower elevation because the Khumbu glacier on which the camp sits is being melted away by climate change, which is undermining its foundation and slowly releasing decades worth of frozen trash and human waste.

But some of the Sherpa climbing guides who make Everest ascents possible are not happy with the idea, arguing that the government should first consider less drastic measures such as limiting the ballooning number of climbing permits, which at around $11,000 apiece have become an important source of revenue for the country.

“I see glaciers vanishing on daily basis. Uncontrollable number of visitors is a problem and it doesn’t make any sense to shift the base camp down,” said Dawa Chhiri Sherpa, 57, who began his career as a cook for a trekking company 35 years ago.

“Consult experts and relevant stakeholders is what should be government doing and not rushing to any decision,” agreed 62-year-old Kay Sherpa, who was born in Scotland and has been living in Nepal since 2009.

He added that the government should try to reduce the influx of helicopters ferrying climbers and other visitors to landing pads at either end of the approximately 22-hectare site to minimize the damage to the ecologically fragile area.

Nepal’s Department of Tourism recommended earlier this summer that a seven-person research group be formed with National Mountaineering Association chairman Nima Nuru Sherpa as its chair. The committee’s mission would be to investigate the present base camp location and potential relocation options.

Taranath Adhikari, director general of the tourism department, said in an interview with the British Broadcasting Corp. that the idea was to move the camp entirely off the fast-receding glacier to a level some 330 meters lower on the mountain.

“It is basically about adapting to the changes we are seeing at the Base Camp, and it has become essential for the sustainability of the mountaineering business itself,” he told the BBC.

The Khumbu glacier has lost the equivalent of 2,000 years of ice in just 30 years, according to research by the 2019 National Geographic and Rolex Perpetual Planet Everest Expedition.

That problem is compounded by the sheer number of visitors to the camp, where more than 1,500 individuals stay for a minimum of two months during the climbing season. Wealthier mountaineers are able to enjoy relatively luxurious accommodations including hot showers, Wi-Fi and catered meals, while acclimatizing to the 5,364-meter altitude.

The proposed move makes sense to Shilshila Acharya, who has played a leading role in efforts to clean up the huge amount of trash that has built up around the base camp since Sir Edmund Hillary and Tenzing Norgay Sherpa first reached the summit in 1953.

“Once the waste is accumulated there, mountain cleanup is very risky and expensive work,” said Acharya, the director of Avni Ventures Pvt Ltd., which is an official recycling partner of Mountain Clean Up Campaign 2021 and 22. Moving the camp would at least temporarily facilitate the clean-up and have safety benefits, she told VOA.

Based on current estimates that the government is spending $1.5 to $2 million a year on the clean-up, “it will take another 50 to 100 years to clean up the existing waste from all mountains,” she said. “So it is going to be costly in the long run if something is not done about it.”

Shafkat Masoodi, a veteran hiker from Kashmir who visited the base camp in 2018, argued that the government must act quickly to move the camp and limit the number of climbing permits issued each season.

“It will prove disastrous in the near future” if they don’t act, he said. “Just imagine the number of climbers per season supported by almost double the number of Sherpas and porters spending at least six months in a year in these glaciers. The garbage and human waste dumped by these is just turning the Khumbu glacier into a polluted river down the mountains.”

But Anja Bagale, operations director at Hotel Himalaya in Kathmandu, pointed out that the current base camp location was selected by experienced Sherpa guides because it is the safest and most practical place from which to launch a final three- to five-day assault on the summit. He argued that the solution is to limit the traffic to the site, not to move it.

Ramesh Bhushal, the Nepal editor of Third Pole and an environment journalist based in Kathmandu, also questioned whether the underlying problems troubling the base camp would be resolved by moving it.

“I don’t see any valid point to shift Everest base camp as it won’t solve any problem as stated and possibly increase problems in [the] future,” he said. “But it is also okay to mull about how to deal with problems that have forced the government to reach into that thought of changing the base camp.”
…

The 60th anniversary of President John F. Kennedy’s “moonshot” speech, which rallied a nation behind NASA. Plus, President Biden calls for a moonshot of his own, and a private spaceflight company suffers its first failure. VOA’s Arash Arabasadi brings us The Week in Space.
…

Russia’s war on Ukraine has seen scores of hospitals and clinics bombed, and frequent power cuts that can turn off lifesaving machines. Medical aid groups are using a Kenyan-manufactured breathing device for premature babies that works without electricity, helping save vulnerable newborns in countries affected by conflict. Victoria Amunga reports from Nairobi, Kenya. Camera – Jimmy Makhulo.
…

With monkeypox cases subsiding in Europe and parts of North America, many scientists say now is the time to prioritize stopping the virus in Africa.

In July, the U.N. health agency designated monkeypox as a global emergency and appealed to the world to support African countries so that the catastrophic vaccine inequity that plagued the outbreak of COVID-19 wouldn’t be repeated.

But the global spike of attention has had little impact on the continent. No rich countries have shared vaccines or treatments with Africa, and some experts fear interest may soon evaporate.

“Nothing has changed for us here. The focus is all on monkeypox in the West,” said Placide Mbala, a virologist who directs the global health research department at Congo’s Institute of Biomedical Research.

“The countries in Africa where monkeypox is endemic are still in the same situation we have always been, with weak resources for surveillance, diagnostics and even the care of patients,” he said.

Rich countries hoard vaccine

Monkeypox has sickened people in parts of West and Central Africa since the 1970s, but it wasn’t until the disease triggered unusual outbreaks in Europe and North America that public health officials even thought to use vaccines. As rich countries rushed to buy nearly all the world’s supply of the most advanced shot against monkeypox, the World Health Organization said in June that it would create a vaccine-sharing mechanism to help needy countries get doses.

So far, that hasn’t happened.

“Africa is still not benefiting from either monkeypox vaccines or the antiviral treatments,” said Dr. Matshidiso Moeti, WHO’s Africa director, adding that only small amounts have been available for research purposes. Since 2000, Africa has reported about 1,000 to 2,000 suspected monkeypox cases every year. So far this year, the Africa Centers for Disease Control and Prevention have identified about 3,000 suspected infections, including more than 100 deaths.

In recent weeks, monkeypox cases globally have fallen by more than a quarter, including by 55% in Europe, according to WHO.

Dr. Ifedayo Adetifa, head of the Nigeria Center for Disease Control, said the lack of help for Africa was reminiscent of the inequity seen during COVID-19.

“Everybody looked after their (own) problem and left everybody else,” he said. Adetifa lamented that monkeypox outbreaks in Africa never got the international attention that might have prevented the virus from spreading globally.

Rich countries have stretched their vaccine supplies by using a fifth of the regular dose, but none have expressed interest in helping Africa. WHO’s regional office for the Americas recently announced it had struck a deal to obtain 100,000 monkeypox doses that will start being delivered to countries in Latin America and the Caribbean within weeks. But no similar agreements have been reached for Africa.

“I would very much like to have vaccines to offer to my patients or anything that could just reduce their stay in the hospital,” said Dr. Dimie Ogoina, a professor of medicine at Niger Delta University in Nigeria and a member of WHO’s monkeypox emergency committee.

Since WHO declared monkeypox a global emergency, Nigeria has seen the disease continue to spread, with few significant interventions.

“We still do not have the funds to do all the studies that we need,” Ogoina said.

Research into the animals that carry monkeypox and spread it to humans in Africa is piecemeal and lacks coordination, said Mbala, of Congo’s Institute of Biomedical Research.

Last week, the White House said it was optimistic about a recent drop in monkeypox cases in the U.S., saying authorities had administered more than 460,000 doses of the vaccine made by Bavarian Nordic.

Cases drop in U.S.

The U.S. has about 35% of the world’s more than 56,000 monkeypox cases but nearly 80% of the world’s supply of the vaccine, according to a recent analysis by the advocacy group Public Citizen.

The U.S. hasn’t announced any monkeypox vaccine donations for Africa, but the White House did make a recent request to Congress for $600 million in global aid.

Even if rich countries start sharing monkeypox tools with Africa soon, they shouldn’t be applauded, other experts said.

“It should not be the case that countries only decide to share leftover vaccines when the epidemic is declining in their countries,” said Piero Olliaro, a professor of infectious diseases of poverty at Oxford University. “It is exactly the same scenario as COVID, and it is still completely unethical.”

Olliaro, who recently returned to the U.K. from a trip to Central African Republic to work on monkeypox, said WHO’s emergency declaration appeared to offer “no tangible benefits in Africa.”

In Nigeria’s Lagos state, which includes the country’s largest city and is hard hit by monkeypox, some people are calling for the government to urgently do more.

“You can’t tell me that the situation wouldn’t have improved without a vaccine,” said Temitayo Lawal, 29, an economist.

“If there is no need for vaccines, why are we now seeing the U.S. and all these countries using them?” he asked. “Our government needs to acquire doses as well.”
…

A second U.S. death was linked to monkeypox on Tuesday as health authorities published a study describing how two previously healthy young men experienced inflammation of the brain and spinal cord as a result of the virus. 

There have been nearly 22,000 U.S. cases in the current global outbreak, which began in May, but new infections have been falling since mid-August as authorities have distributed hundreds of thousands of vaccine doses. 

The latest fatal case involved a severely immunocompromised resident of Los Angeles County who had been hospitalized, the local health department said without revealing further details. 

“Persons severely immunocompromised who suspect they have monkeypox are encouraged to seek medical care and treatment early and remain under the care of a provider during their illness,” the department said. 

The first U.S. death linked to the viral illness occurred in Texas and was announced on August 30, although authorities said that because the person was severely immunocompromised, they were investigating what role monkeypox had played. 

The current global outbreak is primarily affecting men who have sex with men. 

Historically, the virus has been spread via direct contact with lesions, body fluids and respiratory droplets, and sometimes through indirect contamination via surfaces such as shared bedding.  

But in this outbreak, there is preliminary evidence that sexual transmission may also play a role. 

Brain and spinal cord inflammation 

The U.S. Centers for Disease Control and Prevention, meanwhile, published a report about two unvaccinated men in their 30s who experienced brain and spinal cord inflammation after testing positive for the virus. 

The first, patient A, was a gay man in his 30s from Colorado whose symptoms began with fever chills and malaise and progressed to rashes on his face, scrotum and extremities, with swabs of lesions testing positive for the virus. 

He also developed lower extremity weakness and numbness, was unable to empty his bladder, experienced a persistent and painful erection, and was hospitalized. 

Magnetic resonance imaging (MRI) revealed brain and spinal cord inflammation. He was treated with the oral monkeypox antiviral tecovirimat as well as other drugs and began to improve at two weeks. 

He was released but continued to have left leg weakness and required an assistive walking device at a one-month follow-up. 

A second person, patient B, was a gay man in his 30s from Washington. His fever, rashes and muscle pain progressed to bowel and bladder incontinence and progressive flaccid weakness of both legs. 

Brain and spinal cord inflammation was confirmed on MRI, and he was intubated in an intensive care unit, where he was treated with intravenous tecovirimat as well a drug to reduce inflammation and, finally, blood plasma exchange. 

He remains in the hospital but can walk with the assistance of a device. 

The report said the underlying mechanism behind the two cases was unclear — it might have been a direct invasion of the central nervous system or an autoimmune response triggered by monkeypox infection elsewhere in the body. 
…

NASA has so far been unable to launch its first Artemis mission, bringing added scrutiny to a program that is billions of dollars over budget and years behind schedule in returning humans to the moon. VOA’s Kane Farabaugh reports that despite scrubbed launches, the U.S. space agency hopes to get the Artemis program off the ground by the end of the year.
…

Hoping to witness the launch of NASA’s Artemis 1 rocket to the moon is – so far – an exercise in frustration for Mark Franko. 

“I was hoping to feel the noise and the power and the sound – it would have been pretty interesting to see, I think,” Franko told VOA as he and his friends tried to watch a launch behind a local restaurant not far from Cape Canaveral. But fuel leaks and other issues have twice postponed the most powerful rocket system ever created from taking off.   

Despite the delays, Franko’s friend, Mary Jane Patterson, thinks NASA shouldn’t be in a hurry to make the next launch attempt.   

“I think that they should bring it back to the building and really check it out completely and then go again. I feel like it was too soon to go off after the first problem, and I think that, whether it was PR [public relations] or whatever, they were trying to push the envelope but at the same time they can’t. I don’t think you can be too cautious,” she said. 

“It’s the first time we’ve flown this rocket and this capsule,” noted astronaut Stan Love, who spoke with VOA ahead of the first unsuccessful launch attempt. “There are many, many things that can go wrong. This is a test flight. Don’t get your expectations too high.” 

But with hundreds of thousands of tourists gathering in Florida for each launch attempt, joining media from around the world assembled at Cape Canaveral, Love knows those expectations are high, at least partly because of the large price tag of the endeavor. 

The original cost for the S-L-S, or “Space Launch System,” which includes the rocket and boosters that propel the Orion capsule into space, has grown from $10 billion to $20 billion. Each successful launch will cost about $4.1 billion. NASA’s inspector general expects the overall Artemis program to reach $93 billion by the time the first astronauts return to the surface of the moon, targeted for 2025. 

That’s if NASA can get the first uncrewed mission off the ground this year. 

“We’ve got to make sure the vehicle is ready to go, we’ve got to make sure it’s safe for crew, and those things just take time,” said Doug Hurley, a retired NASA astronaut who flew on the first crewed mission of Space X’s Crew Dragon capsule to the International Space Station. He now works for Northrop Grumman, one of the contractors working on Artemis, and he is quick to respond to critics who say the current effort to return to the moon is behind schedule and over budget.   

“I’ve heard that my whole career. Every aircraft I’ve been involved with, every spacecraft I’ve been involved with. We heard that with Crew Dragon flying – it was six years from the time the contract was awarded to the time we flew. It takes time to build these complicated machines. But it’s worth it.” 

As NASA troubleshoots difficulties while carefully weighing the risks in launching Artemis, cost isn’t the only factor.   

“Mission success comes as we assess the flight after the fact,” said David Reynolds, a deputy program manager for NASA, who added that the future of spaceflight depends on the performance of this first uncrewed attempt to return to the moon. 

“As you tick off the different boxes, you buy down a certain amount of risk for the crewed flight. And so, once you have made that determination and we decide that it is safe enough to fly with crew, we will have considered it a mission success.” 

But Mark Franko, who had to return to Tempe, Arizona, before the next potential launch, wonders if the effort to see Artemis 1 in person was worth it. 

“If you watch it on TV it would probably be closer,” he told VOA. 

NASA is now looking at launch windows in late September and early October. 

 
…

As temperatures reach record highs worldwide, air conditioning is becoming more of a necessity. From Somerville, Massachusetts, Matt Dibble has this story of a company hoping to make AC units more efficient.
…